Article Details
Retrieved on: 2022-12-27 09:40:03
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
New Delhi: The Centre on Tuesday approved the cost of Bharat Biotech's nasal COVID-19 vaccine iNCOVACC, which will be used as a booster dose for ...
Article found on: firstindia.co.in
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here